Insight | Hormones and longevity: menopause, optimization and where experts draw lines

September 27, 2026 · 17 min read

Mosconi links menopause to women's Alzheimer's risk, while Attia and Koniver discuss hormone optimization as a longevity lever with differing enthusiasm. Midlife hormone changes turn out to matter well beyond fertility and deserve informed attention.

The insight in about three minutes.

Midlife hormone changes reach well beyond fertility, and the three experts here agree that hormones deserve informed attention, measured levels and a physician's guidance. Where they differ is on how far to push. Hormone therapy decisions depend on personal history, including cancer risk, clotting risk and fertility plans, so make them with a physician experienced in hormone care.

Neuroscientist Lisa Mosconi argues that menopause is a neurological transition. Nearly two-thirds of Alzheimer's patients are women, and she rejects longer life as the whole explanation. Estrogen supports the brain's energy use, immune response and plasticity, and it drops steeply at menopause. In her words, "Estrogen isn't just a reproductive hormone. It's a superpower for your brain." Some women recover cognitively afterward and others decline. On treatment she takes a middle position: hormone therapy may help some women but not all, and plant phytoestrogens from foods such as flaxseeds, chickpeas and soy may be a gentler alternative.

Physician Peter Attia adds bone. Estrogen is the most important hormone regulating bone, and after 65 a broken hip carries roughly a 30 to 40 percent chance of death within a year. He argues that hormone therapy for women was wrongly scared off by the Women's Health Initiative study, which enrolled older, less healthy women, used older drug forms, and whose famous breast cancer headline reflected a rise from about four to five cases per thousand women. He uses a bioidentical estradiol patch with micronized progesterone. On testosterone he draws firm lines: he measures free testosterone and estradiol, doses conservatively, avoids pellets and has rarely treated anyone under about 40. His test is simple: "really the only purpose in my mind of fixing testosterone is to give you the capacity to work harder."

Craig Koniver is the most enthusiastic. He uses peptides that prompt the body to release its own growth hormone, plus testosterone and even nandrolone for select patients. Both he and Andrew Huberman say much of this rests on clinical observation, not published trials. He also warns hard against unsupervised use, telling of a 25-year-old who used testosterone and growth hormone from his late teens and had zero sperm when he wanted children, and against gray-market peptides that can be contaminated.

They agree that hormones matter beyond reproduction, that people respond differently, that pellets and unsupervised use are out, and that hormones should support effort, not replace it. They differ on enthusiasm: Attia calls the peptide field a wild west and noticed nothing from one peptide he tried, because he wants consistent data, while Koniver relies on what he has seen in patients. Attia is clearly supportive of modern estrogen therapy; Mosconi is more reserved. Attia is cautious about testosterone for women because data are lacking.

What to do with it: treat menopause as a brain and bone event and talk with a doctor about symptoms early. If you ruled out hormone therapy because of the old study, ask about absolute risk and modern options. Track bone density and lift heavy. Men should measure free testosterone, binding protein and estradiol before treating, and those under 40 should fix sleep, exercise and nutrition first and protect fertility. If you try peptides, use a physician and a compounding pharmacy.

This is the short form. The full insight has every expert's reasoning, their own words and the sources.

Read next

Report a problem

Something wrong on this page? A mistake, a broken link, audio that won't play? Tell us and we'll fix it.